Gilead Sciences Intangible Assets

Gilead Sciences (GILD) currently reports a intangible assets of $13B as of September 2026. That compares with $18B in the prior-year period — down 26.3% year over year. Use the charts on this page to explore Gilead Sciences's intangible assets history and peer comparisons.

Gilead Sciences's intangible assets decreased from $18B to $13B — a 26.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gilead Sciences reported $13B in intangible assets as of September 2026. That compares with $18B in the prior-year period — down 26.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $13B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gilead Sciences, and consider following GILD for alerts when major investors trade the stock.

Gilead Sciences is classified in the Healthcare sector. On intangible assets, it currently shows $13B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GILD with unrelated industries.